Tuberculosis drug resistance in England and Wales. How much is home-grown'?

Epidemiology and Infection

Volumn 125, Issue 2, 2000, Pages 463-464

  Hayward, A C ^a,b,c   Herbert, J ^a   Watson, J M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; BIRTH; CLASSIFICATION; CONTROLLED STUDY; DISEASE TRANSMISSION; HUMAN; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; TRAVEL; TREATMENT FAILURE; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED KINGDOM;

ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; ENGLAND; HUMANS; ISONIAZID; PHYSICIAN'S PRACTICE PATTERNS; PUBLIC HEALTH; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; WALES;

EID: 0033665299     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899004434     Document Type: Article

References (1)

1. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations 1998